FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 289

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
JUNS Nasdaq Jupiter Neurosciences, Inc. 2830
KALA Nasdaq KALA BIO, Inc. 2830
KAPA Kairos Pharma, Ltd. 2830
KOD Nasdaq Kodiak Sciences Inc. 2830
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2830
KPTI Nasdaq Karyopharm Therapeutics Inc. 2830
KTTA Nasdaq Pasithea Therapeutics Corp. 2830
KVUE New York Kenvue Inc. 2830
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2830
KYTX Nasdaq Kyverna Therapeutics, Inc. 2830
KZR Nasdaq Kezar Life Sciences, Inc. 2830
LBRX Nasdaq LB Pharmaceuticals Inc 2830
LENZ Nasdaq LENZ Therapeutics, Inc. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LIXT Nasdaq Lixte Biotechnology Holdings, Inc. 2830
LNAI Nasdaq Lunai Bioworks Inc. 2830
LQDA Nasdaq Liquidia Corporation 2830
LTRN Nasdaq Lantern Pharma Inc. 2830
LXEO Nasdaq Lexeo Therapeutics, Inc. 2830
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2830
LYEL Nasdaq Lyell Immunopharma, Inc. 2830
LYRA Nasdaq Lyra Therapeutics, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MCRB Nasdaq Seres Therapeutics, Inc. 2830
MDCX Nasdaq Medicus Pharma Ltd. 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MIRA Nasdaq MIRA Pharmaceuticals, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MNMD Nasdaq Mind Medicine (MindMed) Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MTNB Matinas BioPharma Holdings, Inc. 2830
MXCT Nasdaq MaxCyte, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NBY NovaBay Pharmaceuticals, Inc. 2830
NEUP Nasdaq Neuphoria Therapeutics Inc. 2830
NKTR Nasdaq Nektar Therapeutics 2830
NNVC NanoViricides, Inc. 2830
NRIX Nasdaq Nurix Therapeutics, Inc. 2830
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2830
NSRX Nasus Pharma Ltd. 2830
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
NVO New York Novo Nordisk A/S 2830
NVS New York Novartis AG 2830
OGEN Oragenics, Inc. 2830
OGN New York Organon & Co. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
Results 150 through 200 of 289